We have investigated the role of HIF-1 in the cellular response to redox modulation via the inhibition of oxidative phosphorylation. We demonstrate that manipulation of redox in air, achieved by inhibiting cytochrome oxidase with cyanide, induces HIF-1 mediated transcription in wild-type CHO and HT1080 human tumour cells but not in CHO cells de®cient in the oxygen responsive, HIF-1a sub-unit of HIF-1. Hypoglycaemia attenuates cyanide-mediated transcription in nontransformed HIF-1 wild-type CHO cells but not the human tumour derived cell line. Cells lacking either HIF1a, or the second composite sub-unit of HIF-1, HIF-1b, were markedly more sensitive to the combined stress of perturbed redox and hypoglycaemia than wild-type cells. As such conditions together with hypoxia are prevalent in tumours, these data suggest that HIF-1 may have a protective role in adaptation to the tumour microenvironment. In support of this we demonstrate that HIF-1a de®cient cells are less tumorigenic than wild-type cells. They showed a reduced growth rate when grown as xenografts in nude mice. This was not related to vascular parameters that were identical to those found in HIF-1 wild-type tumours. The HIF-1 de®cient tumours lacked focal expression of Glut-1 in hypoxic tumour regions. Compromized glucose uptake and metabolic adaptation to the tumour micro-environment may form the basis of the reduced tumorigenecity associated with these cells.
Introduction
Hypoxia is a common environmental stress prevailing in tumours and is associated with poor therapeutic outcome (reviewed in Teicher, 1994) . Adaptation to this micro-environment is mediated by hypoxia inducible factor-1 (HIF-1) which is a heterodimeric transcription factor comprised of HIF-1a and HIF-1b sub-units. This is achieved via the induction of genes whose expression supports the enforced shift in energy metabolism from oxidative phosphorylation to glycolysis (glut-1, glut-3, PGK-1 amongst others) and enhances oxygen delivery (for example, epo, vegf.). HIF-1 responsive genes can be identi®ed by the presence of a consensus hypoxia responsive element (HRE) enhancer sequence (reviewed in Ratclie et al., 1998) . The precise mechanism linking oxygen depletion to HIF-1 activity is an area of avid research. Perturbations of the mitochondrial respiratory chain under hypoxia have been implicated (Chandel et al., 1998 (Chandel et al., , 2000 Agani et al., 2000) . However, this is contentious, and HIF-1 activation under hypoxia has been demonstrated in cells lacking the mitochondrial respiratory chain electron transport pathway (Srivanas et al., 2001) . More recently, targeted degradation of the HIF-1a subunit of HIF-1 under aerobic conditions has been shown to be dependent on proline hydroxylation (Ivan et al., 2001; Jaakkola et al., 2001) . The activity of proline hydroxylase enzymes has a prerequisite for molecular oxygen and 2-oxoglutarate, a component of the citric acid cycle. Given the importance of adaptive energy metabolism in response to hypoxia, we wished to investigate whether blocking oxygen utilization in oxidative phosphorylation alone is sucient to elicit a HIF-1 mediated transcription response. This was achieved by inhibiting cytochrome oxidase (complex IV) using cyanide.
We used HIF-1 wild-type (wt) and HIF-1a de®cient Chinese hamster ovary (CHO) cells (Wood et al., 1998) transfected with marker constructs for HRE mediated transcription to evaluate the eect of cyanide and associated alterations in mitochondrial redox on HIF-1 transactivation. Under the treatment conditions used, there is a greater reliance on the exogenous glucose supply to fuel energy metabolism via glycolysis. However, tumours are commonly hypoglycaemic, so we investigated the potential role of glucose availability as a modulator of the response of HIF-1 wt and HIF1a de®cient cells to these conditions. Similar experi-ments were carried out using a transfected human tumour cell line (Dachs et al., 1997) and a HIF-1b de®cient hepatoma model (Wood et al., 1996) .
The ability to adapt more readily to the complex micro-environment found in tumours may be associated with a more aggressive tumour phenotype. Murine embryonic stem (ES) cells engineered to lack HIF-1a expression reveal con¯icting data regarding the contribution of HIF-1a to tumour growth (Carmeliet et al., 1998; Ryan et al., 1998) . Ryan et al. (2000) have very recently corroborated their initial ®ndings in ES cells of HIF-1a being a positive factor in solid tumour growth. More consistent data have been reported using xenografts derived from HIF-1b de®cient cells, which have been repeatedly shown to be less tumorigenic than the parental strain, Hepa-1 wt, (Jiang et al., 1997; Maxwell et al., 1997; Stratford et al., 1999) . We have evaluated the tumorigenecity of the CHO derived HIF-1 wt and HIF1a de®cient cells in vivo and correlated the ®ndings of these studies to measurements of vascular density, hypoxic fraction, apoptotic index and expression of the glucose transporter-1 (Glut-1) protein. Glut-1 is induced both by hypoxia and inhibition of oxidative phosphorylation in vitro (Behrooz and Ismail-Beigi, 1997 ). In addition, there is increasing clinical evidence arising that Glut-1 expression is associated with an aggressive tumour phenotype in common cancers and has prognostic signi®cance (Airley et al., 2001 ). This was analysed in both the HIF-1a and HIF-1b de®cient tumours relative to the respective HIF-1 wt parental strains as a marker for an adaptive metabolic response to the environmental conditions prevailing in the tumour.
Results
To investigate the potential importance of adaptive energy metabolism from oxidative phosphorylation to glycolysis in hypoxic signalling, we analysed whether mimicking the mitochondrial eect of hypoxia by inhibiting cytochrome oxidase (complex IV), activated a HIF-1 mediated transcription response. The eect of the cytochrome oxidase inhibitor, cyanide, was evaluated in ®ve transfected cell lines. The CHO derivatives C4.5 and C15, and the human HT1080 ®brosarcoma derived cell lines, 9-3C and 2-C4, all express wt HIF-1. The CHO Ka13.5 strain was derived from C4.5 following drug-induced mutagenesis (Wood et al., 1998) , and lacks HIF-1a expression. The C15 cells have been exposed to the same mutagenic procedure as the Ka13.5 strain, and were therefore used as an additional control to the parental C4.5 cells. All contain HRE-regulated cell surface marker expression constructs (PGK-1 [phosphoglycerate kinase-1] HRE CD-2 and/or EPO [erythropoietin] HRE E-selectin [E-sel]) except 2-C4, where the HRE sequences were omitted (see Materials and methods for full details).
Cyanide in medium containing 20 mM glucose induced HRE-mediated transcription in C4.5, C15 and 9-3C cells, but not in the HIF-1a de®cient Ka13.5 cells or in the 2-C4 cells (Figures 1 and 2 , and data not shown).
However, exposure of the C4.5 and Ka13.5 cells to the mitochondrial complex I inhibitor, rotenone, failed to induce either PGK-1 HRE regulated CD-2 (Figure 1 ) or EPO HRE regulated E-sel expression (data not shown) in these cell lines.
The fold-induction of cell surface marker expression from the PGK-1 HRE in response to cyanide was greater than that obtained from the EPO HRE sequence in the C4.5 cells (data not shown). Similar results were obtained for EPO-HRE marker induction in the C15 cells. In contrast, and in accordance with previously published data (Dachs et al., 1997; Wood et al., 1998) , anoxia resulted in similar induction levels of both the EPO and PGK-1-HRE constructs in the C4.5 cells (5.0+1.0 and 4.6+2.9-fold respectively) and a sixfold induction of PGK-1-HRE mediated expression in the 9-3C cells.
To examine whether glucose availability in¯uenced the transcription response induced by cyanide, we analysed CD-2 and E-sel expression when cells were exposed to medium containing no exogenous glucose. Under these conditions, HRE-mediated marker expression was attenuated in the HIF-1 wt C4.5 and C15 cells ( Figure 2a and data not shown). However, this was not the case in the 9-3C cells where glucose deprivation enhanced the HRE-mediated marker expression elicited by cyanide alone (Figure 2b ). As observed for the cyanide treatment in high glucose conditions, the 2-C4 cells showed no marker induction (Figure 2b ).
Macroscopic analysis of cells exposed to cyanide and hypoglycaemia for 16 h, suggested that the HIF-1a de®cient Ka13.5 cells were much more sensitive to this treatment than either the HIF-1 wt C4.5 or C15 cells. This was con®rmed by an increased proportion of Ka13.5 cells gating within the non-viable (propidium iodide-positive) population, excluded from the¯ow cytometry analysis. Based on morphology, cell death appeared to be via necrosis. In addition, no sub-G 1 peak was observed when the DNA content of pooled populations of attached and detached cells was analysed by¯ow cytometry (data not shown). The eect of cyanide treatment on subsequent cell proliferation was analysed in the C4.5 and Ka13.5 cells by MTT (3-4,5 dimethylthiazol-2,5 diphenyl tetrazolium bromide) assay. Exposure to cyanide in medium containing 20 mM glucose for 16 h had no eect on the subsequent growth of either cell type (Figure 3a) . Both cell types showed compromised growth when simultaneously exposed to glucose depletion and cyanide, but the relative proliferation suggested that the Ka13.5 cells were 4 ± 5-fold more sensitive to this treatment than the C4.5 cells (Figure 3a) . Proliferation of C15 cells was similar to that of the C4.5 cells (50+15% of control). Similar results were obtained for HIF-1b de®cient murine hepatoma cells (Hepa-1 c4) and their parental control, Hepa-1 wt, (Figure 3b ). These results were supported by clonogenic survival data where the colony forming eciency (CFE) of the Hepa-1 wt cells following treatment with hypoglycaemia and cyanide for 16 h was 45+19% (n=3) compared with 10+1% (n=3) for the Hepa-1 c4 cells (expressed relative to the CFE of untreated cells). For all cell types analysed, 16 h exposure to hypoglycaemia without the addition of cyanide did not signi®cantly alter subsequent cell growth, with proliferation observed to at least 95% of untreated control levels.
Using the Ka13.5, C4.5 and C15 strains we found that the HIF-1a de®cient Ka13.5 cells were less tumorigenic in vivo ( Figure 4 ). Titration studies were initially performed using Ka13.5 and HIF-1 wt C15 cells. As these two cell types had been subjected to the same mutagenic procedure that could potentially in¯uence tumour growth, any apparent dierence in take-rate could be related directly to the dierence in HIF-1a status between the cell lines. These studies revealed that a 10-fold greater inoculum of Ka13.5 cells is required for palpable tumour formation compared with the C15 cells (2610 6 versus 2610 5 cells). A comparative study was then performed with the C4.5 cells and revealed similar data to that of the C15 cells. In addition to a reduced take-rate, the subsequent growth of the HIF-a de®cient Ka13.5 tumours was markedly reduced compared to both wt strains ( Figure 4 ).
Quantitative histological analysis revealed that despite the substantial dierences in growth rate, the HIF-1a de®cient Ka13.5 tumours were as well vascularized as the C4.5 and C15 tumours ( Figure 5 , Table 1 ). As can be seen from the representative images presented in Figure  5 , approximately 50% of the vessels are functional, ascertained by overlaying the signal generated for the perfusion marker, Hoechst 33342 (blue) with the vessel map (red). In addition, no dierences were apparent between the tumour types in the relative tumour area binding the bioreductive hypoxic marker, NITP (7-(4-(2-nitroimidazole-l-yl)-butyl)-theophylline (Hodgkiss et al., 1991) ; see Figure 5 , green signal and Table 1 . The extent of apoptosis in the viable areas of the tumours was ascertained using TUNEL (terminal deoxynucleotidyl transferase-mediated d-UTP transferase nick-end labelling) and morphological features to identify apoptotic cells. Again, the overall apoptotic index revealed no dierences dependent on HIF-1 status.
We next analysed the expression of the Glut-1 protein in both the HIF-1a de®cient Ka13.5 and HIF-1b de®cient Hepa-1 c4 tumours relative to HIF-1 wt control tumours (Figure 6 ). In the wt tumours, Glut-1 staining was apparent in the tumour regions bordering necrosis, and co-localized with staining for the hypoxic marker, pimonidazole (1-[(2-hydroxy-3-piperidinyl)propyl]-2-nitroimidazole hydrochloride (Raleigh et al., 1999) ; Figure 6a ,c,e). No Glut-1 staining was apparent in the equivalent regions of HIF-1a or b de®cient tumours (Figure 6b,d,f) .
Discussion
In addition to enhancing oxygen delivery, one of the key roles of the transcription factor HIF-1 is the induction of genes whose products facilitate the enforced shift from oxidative phosphorylation to Figure 1 Cyanide induces HRE-mediated marker transcription in wild-type C4.5 but not HIF-1a de®cient Ka13.5 cells, whereas rotenone elicits no response in either cell type. Data presented are representative pro®les of PGK-1-HRE-mediated CD-2 presentation (FL-2¯uorescence) following 16 h exposure to medium containing 20 mM glucose alone (control, pale area) or medium supplemented with 3 mM KCN or 3 mg ml 71 rotenone (dark line) obtained by¯ow cytometry anaerobic glycolysis under hypoxia. Here we show that inhibition of oxidative phosphorylation alone through treatment with cyanide is sucient to elicit HRE-mediated transcription under aerobic conditions in wild-type HIF-1 cells but not in those lacking HIF1a. Cyanide inhibits cytochrome oxidase (complex IV) and hence blocks oxygen utilization as the terminal electron acceptor in the mitochondrial respiratory chain. Perturbed mitochondrial redox and concomitant generation of reactive oxygen species (ROS) at complex III have recently been implicated as a mechanism of HIF-1a stabilisation (Chandel et al., 2000) . Although the precise contribution of mitochondria to hypoxic signalling is equivocal (Chandel et al., 1998 (Chandel et al., , 2000 Agani et al., 2000; Srinivas et al., 2001) , our ®ndings that inhibition of oxidative phosphorylation can induce HIF-1 mediated transcription are in keeping with those of Chandel et al. (2000) , who induced aerobic expression of HIF-1a through the use of antimycin A (which augments ROS generation at complex III) when the reductive capacity of cells used was diminished through glutathione depletion. In the present study, cyanide elicited a stronger response through the PGK-1-HRE sequence than that seen from the EPO-HRE which may explain why cyanide was shown not to regulate EPO expression in previous studies using dierent systems (Necas and Thornling, 1972; Pugh et al., 1991; Tan and Ratclie, 1991) .
An alternative mechanism for oxygen sensing has recently been elucidated through study of the instability of the HIF-1a sub-unit of HIF-1 in aerobic conditions. This has been attributed to proline hydroxylation of HIF-1a and subsequent targeting for ubiquitin-dependent proteolysis (Ivan et al., 2001; Jaakkola et al., 2001) . In addition to oxygen, the enzyme type responsible for this modi®cation requires 2-oxoglutarate. This is a component of the citric acid cycle, the main purpose of which is to generate reduced nicotinamide adenine dinucleotide (NADH) and¯avin adenine dinucleotide (FADH 2 ) that act as donors of high-energy electron donors to components of the mitochondrial respiratory chain. In the absence of oxygen, or where oxygen utilisation is blocked, both the citric acid cycle and respiratory chain are redundant. Hence, in addition to any potential eects on mitochondrial redox, cyanide may activate HIF-1 in air through the depletion of 2-oxoglutarate and subsequent inhibition of the proline hydroxylase activity required for HIF-1a degradation. Electron transport inhibition by rotenone can be by-passed via FADH 2 which feeds its electrons directly to ubisemiquinone, upstream of the complex I target of rotenone. This may be the basis for why HIF-1 has been shown to be unresponsive to rotenone exposure in the present study, and why rotenone ablates the hypoxic response in others (Chandel et al., 1998 (Chandel et al., , 2000 Srinivas et al., 2001) .
Several lines of evidence suggest complex interplay between the signalling pathways leading to HIF-1 mediated transcription and those resulting from uctuations in glucose availability. These include the fact that the carbohydrate-response element (ChoRE), found upstream of many glycolytic enzymes, has a core consensus sequence (CACGTG) that overlaps that of the HIF-1 binding site (CGTG, Dang et al., 1997) and that the induction of glycolytic enzymes in response to insulin, which would be related to a`high glucose' condition, has been shown to be HIF-1 dependent (Zelzer et al., 1998) . We found that hypoglycaemia ablated cyanide-induced HREmediated transcription in the C4.5 cells. In addition, cells lacking either HIF-1a (Ka13.5) or HIF-1b (Hepa-1 c4) were signi®cantly more sensitive to this treatment than their respective HIF-1 wt cells. In contrast, 9-3C cells derived from the human ®bro-sarcoma cell line HT1080, showed a markedly ampli®ed response to cyanide when depleted of glucose. The basis for the dierence in response between these two cell types is speculative at this point. What may be of importance is that the C4.5 and Ka13.5 strains were derived from Chinese Hamster Ovary (CHO) cells that lack expression of the HIF-2a protein (EPAS; Tian et al., 1997) which shows high sequence homology to HIF-1a and can similarly complex with HIF-1b to initiate HREmediated transcription. The HIF-2a status of the HT1080 strain is not yet known, and hence it is conceivable that the dierential response of the CHO versus HT1080 cells following cyanide and glucose deprivation could re¯ect dierences in HIF-2a. Alternatively, the HT1080 derived 9-3C cells may be able to circumvent the regulatory role of glucose on HIF-1 mediated transcription through activation or loss of a converging pathway. Of interest here is that the ChoRE site is identical to the consensus site for cMyc (Dang et al., 1997) , over-expression of which is common in tumours and may add an extra layer of complexity to HIF-1 and HIF-2 regulated processes.
Our in vitro observations highlighted substantial dierences in the way in which the HIF-1a wt and de®cient cells responded to the inhibition of oxidative phosphorylation and hypoglycaemic stress. We next Figure 5 Representative composite binary images of vascularity (red), perfusion (Hoechst 33342; blue) and hypoxia (NITP labelling; green) in HIF-1 wild-type C4.5 (a) and HIF-1a de®cient Ka13.5 (b) tumours sought to evaluate the in¯uence of HIF-1a on tumorigenesis by initiating tumour xenografts of the C4.5 and Ka13.5 cells in nude mice. Two previous studies that used embryonic stem cells engineered to lack HIF-1a are in disagreement as to the contribution of HIF-1a to tumour growth (Carmeliet et al., 1998; Ryan et al., 1998) . The basis for these con¯icting data is unclear, but may lie with the choice of cell model. To this end, Ryan et al. (2000) have recently substantiated their initial observations that HIF-1a promotes tumour growth, using wt and HIF1a-null H-ras-transformed mouse embryonic ®bro-blasts. However, the underlying mechanism by which Figure 6 Glut-1 protein is focally expressed in HIF-1 wt (C4.5, (a); Hepa-1 wt, (c)) but not HIF-1 de®cient tumours (Ka13.5, (b); Hepa-1 c4, (d)) and co-localizes with regions bordering necrosis (chronically hypoxic; indicated by arrows). Where the hypoxic marker pimonidazole had been administered prior to tumour excision, Glut-1 (c, d) co-localised with pimonidazole staining in adjacent sections (e,f), in wild-type (c,e) but not HIF-1 de®cient (d,f) tumours HIF-1a promotes tumour growth was unclear (Ryan et al., 2000) .
We found the HIF-1a de®cient Ka13.5 cells to be less tumorigenic in vivo than HIF-1 wt cells. The Ka13.5 cells had been subjected to a mutagenic procedure during their selection. An additional wt HIF-1 control line that had been similarly mutagenized was included in the in vivo studies and showed identical properties to the tumours derived from the C4.5 cells. Although we cannot categorically rule out that there may be additional genetic changes in the Ka13.5 strain that may in¯uence tumorigenecity, the data obtained are strongly supportive of HIF-1a being a crucial component. The foundation of the dierential growth rate does not appear to lie in tumour vascularization. This is in complete agreement with the observations of Ryan et al. (2000) , who observed no dierence in the vessel density of HIF-1 wt versus HIF-1a de®cient tumours, despite clear dierences in the expression of vascular endothelial growth factor (VEGF), commonly regarded as the key angiogenic factor in tumorigenesis. None of the CHO-derived strains used in the present study induce VEGF expression when exposed to hypoxia in vitro (Wood et al., 1998) . Although this may be attributable in part to the lack of HIF-2a in these cell lines, breast carcinoma cell lines lacking HIF-2a have been previously shown to express VEGF (Blancher et al., 2000) , suggesting complexities surrounding VEGF expression in dierent cell types.
As VEGF could play no contributory role in the dierential growth rate of our xenograft model, we analysed Glut-1 expression as a marker for HIF-1 mediated metabolic adaptation Ka13.5 and C4.5 tumours. We found that the HIF-1a de®cient Ka13.5 tumours lack focal expression of Glut-1 in hypoxic regions of the tumour and corroborated these ®ndings in HIF-1b de®cient, Hepa-1 c4 tumours. Glut-1 expression has been correlated with the uptake of 18-uorodeoxyglucose in some animal tumour models (Brown et al., 1996; Chung et al., 1999) . The lack of Glut-1 expression (in addition with other HIF-1 activated genes that could in¯uence glycolytic¯ux), may contribute to compromized energy metabolism in HIF-1 de®cient tumours that in turn could in¯uence tumour growth. This is supported by the fact that tumours derived from HIF-1b de®cient, Hepa-1 c4 cells have a fourfold lower ATP content than Hepa-1 wt derived tumours, measured in neutralized extracts by enzymatic assay (Griths et al., 2001) . Despite previous emphasis on VEGF-mediated angiogenesis as the potential basis for dierences in the growth of tumours with and without HIF-1 function, an alternative candidate may lie in metabolic adaptation. Coupled with recent observations that HIF-1 is overexpressed in a range of human malignancies (Zhong et al., 1998 (Zhong et al., , 1999 and can be linked to treatment failure (Birner et al., 2000) , the importance of HIF-1 in tumour growth and response to therapy is becoming increasingly apparent.
Materials and methods

Cell lines and cell culture
All cell lines utilized in this study were routinely cultured in DMEM (Gibco BRL) supplemented with 10% foetal calf serum and 2 mM glutamine in a 95% air: 5% CO 2 environment. All were free from mycoplasma contamination (assayed using Mycotect 1 ; Gibco BRL). The CHO-K1 derivative strain, C4.5, contains two HRE-regulated expression constructs: murine PGK-1-HRE driving the expression of human CD-2 and murine EPO-HRE driving human E-sel expression. The HIF-1a-de®cient Ka13.5 strain was cloned from a population of C4.5 cells following drug-induced mutagenesis (Wood et al., 1998) . As a control for the eects of the mutagenesis procedure, an additional drug-treated CHO-K1 strain (C15) was used, which contains the same EPO-HRE construct as the C4.5 and Ka13.5 cells. C15 represents a mixed cell population, as they had not undergone clonal selection following mutagenesis. The HIF-1b-de®cient cells used (Hepa-1 c4) were derived from the murine hepatoma line Hepa1c1c7 (Hepa-1 wt) and have been described extensively elsewhere (Wood et al., 1996 , and references therein). The human ®brosarcoma HT1080 was transfected with mouse PGK-1-HRE driving CD-2 to give rise to the stable 9-3C strain. 2-C4 cells contain the identical construct, except for the omission of the HRE sequences (Dachs et al., 1997) .
Treatment conditions
Cells were seeded at a concentration of 2610 5 cells per T25 ask (Falcon), left for 24 h and monolayers washed once with glucose-free DMEM prior to the addition of the appropriate treatment medium. Pre-equilibrated glucose-free DMEM (Gibco BRL) supplemented with glucose, FCS, potassium cyanide or rotenone to the ®nal required concentrations (variable for glucose, 10% v/v for FCS, 3 mM for KCN and 3 mg ml 71 for rotenone) was then added for the required incubation time. In comparative studies, cells were subjected to catalyst-induced anoxia in an anaerobic glove cabinet (Forma Scienti®c), containing a 5% CO 2 , 5% H 2 and 90% N 2 environment. For these experiments, cells were bathed in DMEM medium containing 20 mM glucose and 10% (v/v) FCS.
Analysis of HRE-mediated cell surface marker expression
Cells were detached using 2 mM EDTA in phosphatebuered saline (PBS), pelleted and treated with 1% FCS in PBS for 5 min on ice. Cells were pelleted and phycoerythrin (RPE)-conjugated anti-human CD-2 and/or¯uorescein isothiocyanate (FITC) conjugated anti-human E-sel antibodies (Serotec) were added for 10 min on ice according to manufacturers instructions. Cells were washed and resuspended in FACS-¯ow (Becton Dickinson) prior to analysis bȳ ow cytometry (Becton Dickinson). Additional cell aliquots were treated with propidium iodide (PI) to allow the exclusion of non-viable (PI-positive) cells from the analysis.
Cell survival studies
Cells were trypsinized and seeded into multiple wells of a 24-well plate (Falcon) at 1610 4 cells per well in a 0.5 ml volume. 72 h after subculture, 0.5 ml of 1 mg ml 71 MTT (w/v in PBS) was added per well and the plate incubated for 4 h at 378C in a 95% air: 5% CO 2 environment. The medium was aspirated, 1 ml of DMSO added and the optical density of the resulting solution measured at a wavelength of 540 nm using a multiwell spectrophotometer (Titertek twinreader). Additional clonogenic survival assays were performed for some of the cell types to support the data obtained by the MTT proliferation assay. For clonogenic assays, cells were seeded into replicate 6 cm dishes (Falcon) and the CFE following treatment related to that of the relevant control cells, 10 ± 14 days later.
Xenograft studies
To initiate tumour xenografts from the C4.5, Ka13.5 and C15 strains, cells were implanted intra-muscularly at a range of concentrations (2610 5 ± 1610 7 cells) in a 0.1 ml volume of serum-free DMEM in the right hind limb of female nude mice (cba nu/nu, of age 8 ± 11 weeks). Hepa-1 wt and c4 tumours were derived from the inter-dermal injection of 5610 5 cells (prepared as above), 1 cm from the tail base on the midline of the back of the same strain/age mice. Once palpable tumours were established, tumour volume measurements were taken every 2 ± 3 days using callipers. For ethical reasons, tumours were excised prior to achieving a maximum volume of 1000 mm 3 . To allow assessment of the hypoxic regions of the tumours, NITP (140 mg kg 71 in peanut oil containing 10% DMSO) or pimonidazole (Hydroxyprobe-1 TM , Natural Pharmacia International Inc. USA; 60 mg kg 71 in 0.9% w/v saline) were administered by intra-peritoneal injection, 2 or 24 h prior to sacri®ce, respectively. The perfusion marker, Hoechst 33342 (0.6 mg in 0.1 ml PBS) was given 1 min prior to sacri®ce via tail vein injection. All procedures were carried out in accordance with the Scienti®c Procedures Act 1986 and in line with the UKCCCR guidelines 1999, by approved protocols (Home Oce Project Licence number 40 ± 1770).
Immunohistochemical staining procedures
For Glut-1 analysis, formalin ®xed, para®n embedded sections of 3 ± 4 mm in thickness were incubated for 1 h at 378C in the presence of Glut-1 primary antibody (anity pure rabbit anti-human Glut-1, (cross-reactive with rodent Glut-1), Alpha Diagnostic International, USA) at a 1/100 dilution. Control slides were incubated with an identical concentration of a rabbit IgG fraction (DAKO, Denmark). The secondary antibody treatment (horseradish peroxidaseconjugate) and visualization of immunoreactivity (3,3-diaminobenzidine hydrochloride, DAB) was achieved using reagents supplied in the Envision anti-rabbit kit (DAKO, Denmark), according to the manufactures instructions. Where tumour-bearing mice had been treated with pimonidazole, adjacent sections were sequentially treated with 3% H 2 O 2 in water (5 min, room temperature; RT), 0.05% pronase in tris-buered saline (TBS; pH 7.2; 5 min, RT) and 10% casein (10 min, RT), with TBS washes in between. Hydroxyprobe-1MAb1 (mouse monoclonal; Natural Pharmacia International Inc. USA) was applied at a 1/100 dilution for 30 min at RT and staining visualized using the appropriate Envision kit (DAKO, Denmark). Sections were rinsed and counter-stained with Gill's haemotoxylin. The TUNEL (terminal deoxynucleotidyl transferase-mediated d-UTP transferase nick-end labelling) assay was carried out using an apoptag kit (Oncor, Gaithersburg, MD, USA) according to the manufacturer's instructions. Sections were counterstained with 0.5% methyl green, and the extent of apoptosis evaluated by TUNEL positive staining and morphological assessment of at least 2000 cells.
Quantitative analysis of vasculature and hypoxic fraction in the CHO xenograft models
The immunohistochemical staining, image analysis and quantitative procedures allowing simultaneous evaluation of vessel density and hypoxic fraction (NITP incorporation) on a single tumour section have been extensively described elsewhere (Bussink et al., 1998) . Analysis was performed on 5 mm sections prepared from snap frozen tumour samples and all quantitative data is expressed relative to the viable tumour area, determined from H and E stained adjacent sections. Vascular structures were labelled with 9F1 primary antibody and visualized using tetra methylrhodamine isothiocyanate (red) conjugated secondary antibody (Jackson Immunoresearch Laboratories, Pennsylvania, USA). NITP incorporation was detected using rabbit-anti theophylline (Sigma) with ALEXA488 (green) labelled secondary antibody (Molecular Probes, Leiden, The Netherlands).
